Brian O'DwyerBrian O’Dwyer
Chief Executive Officer

Brian O’Dwyer is chief executive officer of Q2 Solutions. Previously, Brian was vice president and general manager of the Americas region for Q2 Solutions, where he was responsible for all operational activity in North and South America.

Brian has more than 20 years of experience in the healthcare and laboratory industry and has broad experience in the establishment, management, integration and restructuring of both business and commercial operations across the clinical research spectrum. Prior to IQVIA, Brian served as senior vice president of the Eurofins Scientific central laboratory business. Brian also was the senior vice president of Global Bioanalytical Services at ICON having previously led ICON’s Early Phase Clinical division in Europe and served as their group financial controller.

Brian holds a bachelor’s degree in business studies from Dublin City University, Ireland, and is a professionally Certified Management Accountant.

Annette BalogAnnette Balog
Chief Commercial Officer 

Annette Balog is the chief commercial officer for Q2 Solutions, where she develops strategic and operational plans to drive the sales and marketing of healthcare products and services for Q2 Solutions’ biopharmaceutical, medical device and diagnostics customers. Balog manages the global sales organizations, marketing and sales operations, for multiple laboratory service lines. Balog brings a 30-year track record in global healthcare-related strategy, sales, marketing and senior leadership. Prior to joining IQVIA, Balog was employed at Zeneca where she held various managerial positions in sales, marketing and managed health care services.

Annette earned a Bachelor of Science in business administration from California State Polytechnic University and a Master of Business Administration from the University of Delaware.

Tony BrownTony Brown
Vice President, General Manager, EMEA

Tony Brown is vice president of EMEA Operations and is responsible for overseeing all aspects of operations in Europe, Middle East and Africa. Previously, Tony was executive director of global operations for Quest Diagnostics' Central Laboratories business. Tony brings more than 28 years of experience in the diagnostics and central laboratory business to the joint venture.

Tony earned Bachelor of Science Degrees in finance and computer science from the State University of New York, Plattsburgh, and earned a Master of Business Administration in Health Systems Administration from Union University, Graduate Management Institute.

Mike FedockMike Fedock
Chief Financial Officer

Mike Fedock is chief financial officer, where he brings more than 18 years in the contract research organization and life science sector in finance and operational leadership roles. Previously, Fedock was vice president, early phase development at ICON, where he held positions of increasing responsibility in finance overseeing the global Early Phase and Pharmacokinetic business units.

Mike earned a Bachelor of Science in Biology from Drexel University and a Master of Business Administration from the University of Baltimore.


Patrice HugoPatrice Hugo
Chief Scientific Officer

Dr. Hugo is the chief scientific officer, and he brings more than 25 years of senior scientific leadership experience with extensive management expertise in laboratory operations applied to diagnostics, therapeutic targets and clinical trials. Most recently, Dr. Hugo was associate vice president and Chief Scientist at LabCorp/Covance. He has held several other senior leadership positions at companies including Clearstone Central Laboratories, Caprion and PROCREA BioSciences. A noted industry expert, Dr. Hugo has more than 75 scientific publications in internationally renowned journals. He also is active in a number of industry organizations, including his role on the Board of Directors for the non-for-profit Personalized Medicine Partnership for Cancer in Quebec, Warnex, offering analytical and bioanalytical services and his role as a steering committee member for the Biomarker Factory.

Dr. Hugo obtained a Ph.D. at McGill University and completed five years of post- doctoral fellowship at the Walter Elisa Hall Institute in Australia, and Howard Hughes Medical Institute.

Kevin JonesKevin Jones
Vice President, General Manager, Bioanalytical and ADME Services

Kevin Jones is the vice president and general manager for Bioanalytical and ADME services, where he is responsible for all operational aspects of our Bioanalytical and ADME Laboratories. Kevin brings more than 20 years of experience in supporting fee for service analytical laboratories. Previously Kevin was executive director, chemistry solutions for Covance where he held various senior leadership roles both in North America and globally, in which he was responsible for the operational oversight of multiple bioanalytical locations performing regulated bioanalysis clinical and non-clinical studies. Kevin began his career with AAIPharma, leading teams responsible for laboratory operations, sales and commercial support for GMP/GLP laboratory services.

Kevin earned a Bachelor Degree in Chemistry and a Masters of Business Administration from the University of North Carolina at Wilmington.

Caroline KeaneCaroline Keane
Senior Vice President, Project Services

Caroline Keane is senior vice president of project services, where she has leadership responsibilities for global project services, including project management, data management and study setup. Caroline joined IQVIA in 2014 as vice president of project services in global central laboratories. Prior to IQVIA, Caroline was responsible for global project management, data management and investigator site support at LabCorp.

Caroline earned a Bachelor of Science from the University of Toronto and a Master of Business Administration from Simon Fraser University.

Brian O'DwyerBrian O’Dwyer
Interim Vice President, General Manager, Americas

Brian O’Dwyer is the interim vice president and general manager of the Americas region, where he is responsible for all operational activity in North and South America. Brian has more than 20 years of experience in the healthcare and laboratory industry and has broad experience in the establishment, management, integration and restructuring of both business and commercial operations across the clinical research spectrum. Previously, Brian served as senior vice president of the Eurofins Scientific central laboratory business. Prior to his role at Eurofins Scientific, Brian was senior vice president of Global Bioanalytical Services at ICON having previously led ICON’s Early Phase Clinical Division in Europe and served as their Group Financial Controller before that.

Brian earned a Bachelor of Business studies from Dublin City University, Ireland and is a professionally Certified Management Accountant.


Guy RachmuthGuy Rachmuth
Vice President, Global Head of Strategy 

Guy Rachmuth, Ph.D., is the global head of strategy and corporate development, where he leads a focused market-based insights team to drive strategy that supports Q2 Solutions’ goal of improving human health through innovation. Previously, Dr. Rachmuth was a director of corporate strategic services for IQVIA, leading the clinical development strategic planning process. Prior to joining IQVIA, he led corporate development and strategy for M*Modal, a $500M healthcare IT company. Dr. Rachmuth is an experienced entrepreneur, founding and leading several companies including HEALTHeME INC in 2009, a pioneering mobile health company leveraging AI technology, and NeuroAnalogics Inc. an innovative hardware-based brain-machine interface company spun out of MIT.

Dr. Rachmuth earned an M.S. and Ph.D. from Harvard University in Biomedical Engineering under the Harvard/MIT Health Sciences and Technology (HST) program, and a Bachelor of Science in Biomedical Engineering at Boston University.

Simon ThornleySimon Thornley
Vice President, Quality and Compliance

Simon Thornley is vice president of quality and compliance, where he leads world-class quality and compliance systems within the new organization. With more than 20 years of quality assurance (QA) experience supporting pharmaceutical industry clients, Simon was previously the global director of QA and regulatory affairs for Quest Diagnostics clinical trials. This included managing a global program of quality and compliance audits across technical and non-technical business processes, hosting client and regulatory audits, managing client QA relationships, and supporting the business in meeting the industry's high expectations of quality.

Simon earned a Bachelor of Science from the Nottingham Trent University.

Jian Wang
CEO, BioFortis, Inc.

Dr. Wang is the CEO of BioFortis, the precision medicine and technology solutions offering, a Q2 Solutions company. For more than 20 years, Dr. Wang developed several software products with pharmaceutical customers, government agencies, and academia. He has deep knowledge in the rapidly evolving field of precision medicine and its associated biomarker-driven clinical trials, and strives to bring precision medicine technology solutions to researchers to help solve real-world health problems.

Dr. Jian Wang received his Ph.D. in Bioengineering from the University of Washington

Kellie YarnellKellie Yarnell
Vice President, General Manager, Genomics Laboratories

Kellie Yarnell is vice president of genomics laboratories, where she leads our genomics efforts and organization. Previously, Kellie led genomic operations for Expression Analysis, an organization specializing in next-generation sequencing and bioinformatics services supporting the biopharmaceutical clinical trial and research market. Kellie brings more than 15 years of commercial expertise, scientific aptitude and strategic vision in the genomics space to the organization.

Kellie earned a Bachelor of Science in Biochemistry from the University of Delaware.

Jenny ZhangJenny Zhang
Vice President, General Manager, Asia-Pacific Operations

Jenny Zhang is vice president of Asia-Pacific operations, where she is responsible for overseeing all aspects of operations for the organization in Asia-Pacific. Previously, Jenny was vice president and general manager of IQVIA's central laboratories for the Asia-Pacific laboratories. Based in Singapore, Jenny brings more than 18 years of experience to the joint venture leadership team, which includes various leadership positions at IQVIA and LabCorp.

Jenny Zhang received a Master of Science and a Master of Business Administration from Tsinghua University.